Royal Brompton & Harefield NHS Foundation Trust
Nizar is a Consultant Thoracic Surgeon with special interest in minimal invasive surgery. He trained in thoracic surgery in several hospitals including Royal
Brompton, Harefield and Great Ormond Street Hospital. He completed his CCT in Italy in the University of Bologna in 2014; following that he moved to UK and completed multiple fellowships in Thoracic and tracheal Surgery. He was recently appointed as Thoracic Consultant in Harefield Hospital, one of the worlds leading hospitals for cardiothoracic surgery. He is a researcher and currently leading multiple projects in thoracic adult and paediatric surgery, with a special interest in quality of life and enhanced recovery after surgery. He has presented and lectured at multiple national and international conferences and currently is an active member of the European Society of Thoracic Surgeons.
Thoracic surgery in the treatment of lung cancer
Lung cancer is the most frequent cause of cancer-related deaths worldwide. 20% of patients diagnosed with lung cancer will be a candidate for radical surgical treatment. Surgery currently is the gold-standard treatment for early stages of lung cancer; however with introducing new treatments the role of surgery is becoming more limited. How do those evolutions affect the role of surgery in the treatment of lung cancer? How Thoracic surgery is evolving with the new technologies?
EVEN MORE SEMINARS
Prof Adam Waldman MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging
Biomarkers in Adult Glioma
Imran Liaquat MBChB BSc MedSci MRCS FRCS MEd NHS Lothian, Scotland
Optimising Surgical Resection in Low Grade Glioma Patients
Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath University Hospital Southampton NHS Foundation Trust.
Targeted therapies: aiming at the tumour micro-environment
Sanjay P Prabhu Boston Children’s Hospital & Harvard Medical School
Evolving role of machine learning in brain tumour imaging
Philip Beer MRCP, FRCPath, PhD ONCODNA S.A
The evolution of oncology therapeutics in the genomic era.